ATE286536T1 - Bindungs domänen von plasmodium vivax und plasmodium falciparum erythrozyten-bindenden proteinen - Google Patents

Bindungs domänen von plasmodium vivax und plasmodium falciparum erythrozyten-bindenden proteinen

Info

Publication number
ATE286536T1
ATE286536T1 AT94929779T AT94929779T ATE286536T1 AT E286536 T1 ATE286536 T1 AT E286536T1 AT 94929779 T AT94929779 T AT 94929779T AT 94929779 T AT94929779 T AT 94929779T AT E286536 T1 ATE286536 T1 AT E286536T1
Authority
AT
Austria
Prior art keywords
plasmodium
vivax
binding
binding domains
polypeptides
Prior art date
Application number
AT94929779T
Other languages
English (en)
Inventor
Kin Lee Sim
Chetan Chitnis
Louis H Miller
David S Peterson
Xin-Zhuan Su
Thosmas E Wellems
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE286536T1 publication Critical patent/ATE286536T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT94929779T 1993-09-10 1994-09-07 Bindungs domänen von plasmodium vivax und plasmodium falciparum erythrozyten-bindenden proteinen ATE286536T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11967793A 1993-09-10 1993-09-10
PCT/US1994/010230 WO1995007353A2 (en) 1993-09-10 1994-09-07 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins

Publications (1)

Publication Number Publication Date
ATE286536T1 true ATE286536T1 (de) 2005-01-15

Family

ID=22385690

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94929779T ATE286536T1 (de) 1993-09-10 1994-09-07 Bindungs domänen von plasmodium vivax und plasmodium falciparum erythrozyten-bindenden proteinen

Country Status (10)

Country Link
US (3) US5849306A (de)
EP (1) EP0719333B1 (de)
JP (1) JPH09502353A (de)
CN (3) CN1134173A (de)
AT (1) ATE286536T1 (de)
AU (1) AU694142B2 (de)
CA (1) CA2171193A1 (de)
DE (1) DE69434221T2 (de)
HK (1) HK1010395A1 (de)
WO (1) WO1995007353A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69434221T2 (de) * 1993-09-10 2006-01-19 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Bindungsdomänen von Plasmodius Vivax und Plasmodium Falciparum Erythrozyten bindenden Proteinen
US5993827A (en) * 1993-09-10 1999-11-30 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
SE9703386D0 (sv) * 1997-09-19 1997-09-19 Karolinska Innovations Ab Malaria polypeptides
US7459524B1 (en) * 1997-10-02 2008-12-02 Emergent Product Development Gaithersburg Inc. Chlamydia protein, sequence and uses thereof
AU2004201615B2 (en) * 1999-03-04 2007-01-25 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Anti-plasmodium compositions and methods of use
US7025961B1 (en) 1999-03-04 2006-04-11 The United States Of America As Represented By The Department Of Health And Human Services Anti-plasmodium composition and methods of use
JP2002540770A (ja) * 1999-03-04 2002-12-03 エントレメッド インコーポレイテッド 抗マラリア原虫組成物および使用法
WO2002011756A2 (en) * 2000-08-07 2002-02-14 Entremed, Inc. Anti-plasmodium compositions and methods of use
AU2002338238A1 (en) * 2001-04-02 2002-10-15 The Government Of The United States Of America, As Represented By The Secretary, Department Of Healt Plasmodium falciparum erythrocyte binding protein baebl for use as a vaccine
JP4214225B2 (ja) * 2001-10-15 2009-01-28 独立行政法人農業生物資源研究所 抗微生物蛋白質、それをコードする遺伝子及びそれらの利用法
US7078507B2 (en) * 2001-11-09 2006-07-18 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Synthetic genes for malarial proteins and methods of use
PE20080428A1 (es) * 2006-07-18 2008-05-15 Glaxosmithkline Biolog Sa Vacunas para la malaria
US7773575B2 (en) * 2006-07-24 2010-08-10 Harris Corporation System and method for communicating using a plurality of TDMA mesh networks having efficient bandwidth use
CN101921337B (zh) * 2010-07-21 2013-05-08 上海市疾病预防控制中心 间日疟原虫乳酸脱氢酶抗体、相关制备方法、杂交瘤细胞株和应用
US8784832B2 (en) * 2011-08-19 2014-07-22 University Of South Florida (A Florida Non-Profit Corporation) Synthetic antigen based on the ligand domain of the Plasmodium vivax duffy binding protein
CN110343161B (zh) * 2019-07-30 2021-08-20 暨南大学 一种检测恶性疟原虫hrp2和间日疟原虫ldh的结合蛋白组合及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5144007A (en) * 1988-11-03 1992-09-01 La Jolla Cancer Research Foundation Thyroid hormone receptor
US5198347A (en) * 1990-07-20 1993-03-30 The United States Of America As Represented By The Department Of Health And Human Services Dna encoding plasmodium vivax and plasmodium knowlesi duffy receptor
DE69329145D1 (de) * 1992-03-11 2000-09-07 Kenneth Francis Prendergast Anti-virale Fusionspeptide
DE69434221T2 (de) 1993-09-10 2006-01-19 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Bindungsdomänen von Plasmodius Vivax und Plasmodium Falciparum Erythrozyten bindenden Proteinen
US5993827A (en) * 1993-09-10 1999-11-30 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins

Also Published As

Publication number Publication date
US20020169305A1 (en) 2002-11-14
AU7872194A (en) 1995-03-27
CN1414102A (zh) 2003-04-30
JPH09502353A (ja) 1997-03-11
CA2171193A1 (en) 1995-03-16
CN1134173A (zh) 1996-10-23
US6392026B1 (en) 2002-05-21
US5849306A (en) 1998-12-15
AU694142B2 (en) 1998-07-16
US6962987B2 (en) 2005-11-08
CN1414018A (zh) 2003-04-30
DE69434221D1 (de) 2005-02-10
DE69434221T2 (de) 2006-01-19
WO1995007353A2 (en) 1995-03-16
EP0719333A1 (de) 1996-07-03
HK1010395A1 (en) 1999-06-17
WO1995007353A3 (en) 1995-06-01
EP0719333B1 (de) 2005-01-05

Similar Documents

Publication Publication Date Title
ATE286536T1 (de) Bindungs domänen von plasmodium vivax und plasmodium falciparum erythrozyten-bindenden proteinen
WO1996040766A3 (en) Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
DK0833649T3 (da) Proteinhydrolysatpræparater til forebyggelse eller behandling af allergier og fremgangsmåder til fremstilling og anvendelser deraf
DK1854471T3 (da) Apolipoprotein A-I-agonister og anvendelse deraf til behandling af dyslipidæmiske forstyrrelser
ATE212378T1 (de) Stressproteine und ihre verwendung
DK1032662T3 (da) Fremgangsmåder og sammensætninger til immunmodulation
EP1264890A3 (de) Plasmodium vivax Blutphaseantigene, dagegen gerichtete Antikörper und diagnostische Verfahren
DK0839196T3 (da) Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner
DE69026022D1 (de) Membrane hergestellt aus Copolymeren von Polyimiden und aliphatischen Polyestern .
WO2002011756A3 (en) Anti-plasmodium compositions and methods of use
DK124087A (da) Immunogent peptidantigen svarende til plasmodium vivax circumsporozoitprotein
DE3583347D1 (de) Klonieren von dna fuer protozoenantigene.
GR3036782T3 (en) Proteases capable of shedding the soluble TNF-receptor and TNF-R derived peptides and antibodies against the proteases inhibiting the shedding.
ATE331037T1 (de) Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff
ATE256183T1 (de) Neue proteine von parasitischen würmern
ES2129426T3 (es) Polipeptidos antitrombinicos.
DE60036555D1 (de) Polypeptidfragmente mit einem c-terminalen teil von katalase aus helicobacter
DE59406332D1 (de) Niedrigviskose wässrige konzentrate von betaintensiden
DE69413009D1 (de) Verwendung von antikörpern gegen pdgf-rezeptoren zur inhibierung von hyperplasie der intima
WO1995008631A3 (en) Target antigens of transmission blocking antibodies for malaria parasites
MY104081A (en) Rhoptry membrane antigen of plasmodium falciparum.
WO2000052056A3 (en) Anti-plasmodium compositions and methods of use
IT1270941B (it) Peptidi di hcv e loro usi.
WO2004052914A3 (en) Compositions and methods for inhibiting malaria protease falcipain-2
方军 et al. Observation on the specific binding site of p195 protein on human erythrocytes using colloidal gold labelling

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties